Iterum Therapeutics (ITRM) Accounts Payables (2017 - 2022)
Historic Accounts Payables for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $1.2 million.
- Iterum Therapeutics' Accounts Payables rose 34528.99% to $1.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.2 million, marking a year-over-year increase of 34528.99%. This contributed to the annual value of $878000.0 for FY2021, which is 759.8% up from last year.
- According to the latest figures from Q3 2022, Iterum Therapeutics' Accounts Payables is $1.2 million, which was up 34528.99% from $787000.0 recorded in Q2 2022.
- In the past 5 years, Iterum Therapeutics' Accounts Payables registered a high of $15.5 million during Q4 2019, and its lowest value of $276000.0 during Q3 2021.
- In the last 5 years, Iterum Therapeutics' Accounts Payables had a median value of $2.4 million in 2020 and averaged $4.5 million.
- In the last 5 years, Iterum Therapeutics' Accounts Payables surged by 43644.76% in 2019 and then tumbled by 9473.07% in 2020.
- Iterum Therapeutics' Accounts Payables (Quarter) stood at $4.0 million in 2018, then soared by 283.22% to $15.5 million in 2019, then crashed by 94.73% to $816000.0 in 2020, then grew by 7.6% to $878000.0 in 2021, then skyrocketed by 39.98% to $1.2 million in 2022.
- Its Accounts Payables stands at $1.2 million for Q3 2022, versus $787000.0 for Q2 2022 and $684000.0 for Q1 2022.